HEADER HORMONE 25-NOV-08 2KBC TITLE SOLUTION STRUCTURE OF HUMAN INSULIN-LIKE PEPTIDE 5 (INSL5) COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSL5_B-CHAIN; COMPND 3 CHAIN: B; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: INSL5_A-CHAIN; COMPND 7 CHAIN: A; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 4 ORGANISM_TAXID: 469008; SOURCE 5 OTHER_DETAILS: PEPTIDE CHAIN WAS ASSEMBLED USING FMOC SOLID PHASE SOURCE 6 PEPTIDE SYNTHESIS AND COMBINED WITH THE A-CHAIN USING REGIOSELECTIVE SOURCE 7 DISULFIDE BOND FORMATION; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 11 ORGANISM_TAXID: 469008; SOURCE 12 OTHER_DETAILS: PEPTIDE CHAIN WAS ASSEMBLED USING FMOC SOLID PHASE SOURCE 13 PEPTIDE SYNTHESIS AND COMBINED WITH THE B-CHAIN USING REGIOSELECTIVE SOURCE 14 DISULFIDE BOND FORMATION KEYWDS PEPTIDE HORMONE, RELAXIN, INSULIN-LIKE FOLD, HORMONE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR K.J.ROSENGREN,L.M.HAUGAARD-JONSSON REVDAT 4 25-DEC-19 2KBC 1 REMARK DBREF SEQRES LINK REVDAT 3 07-FEB-18 2KBC 1 SOURCE REMARK REVDAT 2 21-APR-09 2KBC 1 JRNL REVDAT 1 24-MAR-09 2KBC 0 JRNL AUTH M.A.HOSSAIN,N.L.DALY,D.J.CRAIK,J.D.WADE,K.J.ROSENGREN JRNL TITL STRUCTURE OF HUMAN INSULIN-LIKE PEPTIDE 5 AND JRNL TITL 2 CHARACTERIZATION OF CONSERVED HYDROGEN BONDS AND JRNL TITL 3 ELECTROSTATIC INTERACTIONS WITHIN THE RELAXIN FRAMEWORK JRNL REF BIOCHEM.J. V. 419 619 2009 JRNL REFN ISSN 0264-6021 JRNL PMID 19178384 JRNL DOI 10.1042/BJ20082353 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TOPSPIN 2.1, CNS 1.2 REMARK 3 AUTHORS : BRUKER BIOSPIN (TOPSPIN), BRUNGER, ADAMS, CLORE, REMARK 3 GROS, NILGES, READ (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURES WERE GENERATED USING TORSION REMARK 3 -ANGLE DYNAMICS AND SUBSEQUENTLY REFINED AND ENERGY MINIMIZED REMARK 3 USING CARTESIAN DYNAMICS AND POWELL MINIMIZATION IN EXPLICIT REMARK 3 SOLVENT WITHIN THE PROGRAM CNS. REMARK 4 REMARK 4 2KBC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 27-NOV-08. REMARK 100 THE DEPOSITION ID IS D_1000100909. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298; 298 REMARK 210 PH : 4; 4 REMARK 210 IONIC STRENGTH : 0; 0 REMARK 210 PRESSURE : AMBIENT; AMBIENT REMARK 210 SAMPLE CONTENTS : 0.2 MM INSL5, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D DQF-COSY; 2D 1H-1H TOCSY; 2D REMARK 210 1H-1H NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 900 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN 2.1, CARA 1.5, CYANA 2.0 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU B 10 HH12 ARG B 13 1.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 THR A 9 -68.99 -138.17 REMARK 500 2 THR A 9 -74.57 -102.12 REMARK 500 3 ASP A 10 -44.69 -130.40 REMARK 500 4 ASP A 10 -50.22 -127.77 REMARK 500 5 ASP A 10 -60.30 -105.44 REMARK 500 7 THR A 9 -74.65 -100.43 REMARK 500 8 SER B 3 96.10 -69.87 REMARK 500 8 THR A 9 -74.15 -91.61 REMARK 500 10 THR A 9 -73.84 -93.42 REMARK 500 11 THR A 9 -71.43 -130.79 REMARK 500 12 THR A 9 -75.70 -115.94 REMARK 500 13 SER B 3 -167.32 -165.24 REMARK 500 13 THR A 9 -72.58 -106.90 REMARK 500 15 THR A 9 -71.90 -97.02 REMARK 500 18 SER B 3 -168.25 -162.62 REMARK 500 19 THR A 9 -72.32 -113.97 REMARK 500 20 THR A 9 -74.88 -96.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH2 B 25 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH2 A 22 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2K1V RELATED DB: PDB REMARK 900 STRUCTURE OF INSL5/RELAXIN-3 CHIMERA REMARK 900 RELATED ID: 2FHW RELATED DB: PDB REMARK 900 STRUCTURE OF THE RELATED PEPTIDE RELAXIN-3 DBREF 2KBC B 1 25 PDB 2KBC 2KBC 1 25 DBREF 2KBC A 1 22 PDB 2KBC 2KBC 1 22 SEQRES 1 B 25 LYS GLU SER VAL ARG LEU CYS GLY LEU GLU TYR ILE ARG SEQRES 2 B 25 THR VAL ILE TYR ILE CYS ALA SER SER ARG TRP NH2 SEQRES 1 A 22 PCA ASP LEU GLN THR LEU CYS CYS THR ASP GLY CYS SER SEQRES 2 A 22 MET THR ASP LEU SER ALA LEU CYS NH2 MODRES 2KBC PCA A 1 GLN PYROGLUTAMIC ACID HET NH2 B 25 3 HET PCA A 1 14 HET NH2 A 22 3 HETNAM NH2 AMINO GROUP HETNAM PCA PYROGLUTAMIC ACID FORMUL 1 NH2 2(H2 N) FORMUL 2 PCA C5 H7 N O3 HELIX 1 1 GLY B 8 TRP B 24 1 17 HELIX 2 2 THR A 5 THR A 9 5 5 HELIX 3 3 SER A 13 CYS A 21 1 9 SSBOND 1 CYS B 7 CYS A 8 1555 1555 2.03 SSBOND 2 CYS B 19 CYS A 21 1555 1555 2.03 SSBOND 3 CYS A 7 CYS A 12 1555 1555 2.03 LINK C TRP B 24 N NH2 B 25 1555 1555 1.33 LINK C PCA A 1 N ASP A 2 1555 1555 1.32 LINK C CYS A 21 N NH2 A 22 1555 1555 1.33 SITE 1 AC1 3 ALA B 20 SER B 21 TRP B 24 SITE 1 AC2 4 SER A 18 ALA A 19 LEU A 20 CYS B 19 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1